期刊文献+

抑癌基因ARHI在子宫内膜异位症及非子宫内膜异位症患者中差异表达的意义 被引量:6

Differential expression of the anti-oncogene ARHI between patients with and without endometriosis
下载PDF
导出
摘要 目的研究子宫内膜异位症(endometriosis,EMs)组织中抑癌基因ARHI的mRNA和蛋白表达情况。方法利用RT-PCR和Western Blot免疫印迹的方法,对EMs的异位内膜组织、在位内膜组织和非EMs在位内膜组织(正常内膜组织)进行mRNA和蛋白表达的半定量分析。利用原位杂交和免疫组化技术对研究各组进行定性及定位分析。结果 (1)ARHI mRNA和蛋白在各组中均有表达,异位内膜的表达高于在位内膜和正常内膜,差异显著(P<0.005),在位内膜组与正常对照组比较,ARHI的表达无明显差异(P>0.05);(2)原位杂交阳性率分别为非EMs组97.3%,EMs异位内膜组100%,EMs在位内膜组93.8%;(3)免疫组化阳性率分别为非EMs组93.2%,EMs异位内膜组100%,EMs在位内膜组92.3%;(4)ARHI的DNA与蛋白表达一致;(5)5例恶变的异位内膜ARHI免疫组化检测,4例呈阴性,1例呈弱阳性表达。结论抑癌基因ARHI在子宫内膜组织中均表达,且在异位内膜中呈表达上调,而在恶变的异位内膜中多呈阴性表达,提示ARHI基因可能与子宫内膜异位症不孕及恶变相关。 Objective To investigate the expression of the anti-oncogene ARHI in the endometriotic tissue and explore its clinical significance.Methods A semiquantitative analysis of the expression of ARHI mRNA and protein in the ectopic and eutopic endometrium of women with endometriosis was conducted using RT-PCR and Western blotting in comparison with that in the endometrium of women without endometriosis.Immunohistochemisty and in situ hybridization were performed for semiqualitative analysis and localization of ARHI expression.Results The expression levels of ARHI mRNA and protein differed significantly between the groups.ARHI was expressed at significantly higher levels in ectopic endometrium than in eutopic and normal endometrium(P0.005) ,but showed no significant difference between the latter two tissues(P0.05) .The positivity rate ARHI DNA was 97.3% in the endometrium of women without endometriosis,100% in the ectopic endometrium and 93.8% in the eutopic endometrium of women with endometriosis.Immunohistochemisty showed an ARHI positivity of 93.2% in the endometrium of women without endometriosis,100% in the ectopic endometrium and 92.3% in the eutopic endometrium of women with endometriosis.The expression patterns of ARHI DNA and protein were consistent.Immunohistochemisty in 5 cases of malignant endometriosis showed negative ARHI expression in 4 cases and weak positivity in 1 case.Conclusion ARHI expressions are present in the endometrium and up-regulated in ectopic endometrium,whereas in the ectopic endometrium of patients with malignant endometriosis its expression is often negative,suggesting a role of ARHI in infertility and tumorigenesis of endometriosis.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2011年第5期796-800,共5页 Journal of Southern Medical University
基金 国家自然科学基金(39830350) 解放军总医院苗圃基金(06MP43)~~
关键词 子宫内膜异位症 抑癌基因 不孕 恶变 ARHI endometriosis tumor suppressor gene infertility canceration ARHI
  • 相关文献

参考文献10

  • 1Yu Y, Xu F, Peng H, et al. NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas[J]. Proc Natl Acad Sci USA, 1999, 96(1): 214-9.
  • 2Rosen DG, Wang L, Jain AN, et al. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival [J]. Clin Cancer Res, 2004, 10(19): 6559-66.
  • 3Yang J, Hu A, Wang L, et al. NOEY2 mutations in primary breast cancers and breast hyperplasia[J]. Breast, 2009, 18(3): 197-203.
  • 4李洁,李亚里,田方,宗利丽,李亭.表达谱基因芯片筛选子宫内膜异位症相关基因及IL-12受体在子宫内膜异位症中的作用[J].现代妇产科进展,2004,13(4):255-257. 被引量:5
  • 5汪淑娟,李亚里,蒋红清.新抑癌基因ARHI在子宫内膜异位症中的表达及其意义[J].现代妇产科进展,2006,15(11):851-853. 被引量:5
  • 6Xu F, Xia W, Luo RZ, et al. The human ARHI tumor suppressor gene inhibits lactation and growth in transgenic mice [J]. Cancer Res, 2000, 60(17): 4913-20.
  • 7Mandai M, Yamaguchi K, Matsumura N, et al. Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management[J], Int J Clin Oncol, 2009, 14(5): 383-91.
  • 8Ness RB. Endometriosis and ovarian cancer: thoughts on shared pathophysiology[J]. Am J Obstet Gynecol, 2003, 189(1): 280-94.
  • 9沈文洁,邢福祺,鲁永鲜,孔令红.印迹抑癌基因ARHI在浆液性卵巢癌中的表达及甲基化研究[J].解放军医学杂志,2008,33(3):302-304. 被引量:7
  • 10Feng W, Marquez RT, Lu Z, et al. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation[J]. Cancer, 2008, 112(7): 1489-502.

二级参考文献25

  • 1李洁,李亚里,田方,宗利丽,李亭.表达谱基因芯片筛选子宫内膜异位症相关基因及IL-12受体在子宫内膜异位症中的作用[J].现代妇产科进展,2004,13(4):255-257. 被引量:5
  • 2Giudice L,Tazuke S,Swiersz L.Status of current research on endometriosis[J].J Reprod Med,1998,43(3 Suppl):252-262
  • 3Ermolaeva O,Rastogi M,Pruitt KD,et al. Data management and analysis for gene expression arrays[J].Nat Genet,1998,20:19-23
  • 4Hsieh CS,Macatonia SE,Tripp CS,et al. Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages[J].Science,1993,260:547-549
  • 5Szczepanska M,Mikolajczyk M,Raczynska P,et al.The evaluation of IL-12 levels in peritoneal fluid and serum of women with endometriosis[J].Ginekol Pol,2001,72:408-417
  • 6Desai BB,Quinn PM,Wolitzky AG,et al.IL-12 receptor II distribution and regulation of receptor expression[J].J Immunol,1992,148:3125-3132
  • 7Yu Y,Xu F,Peng H,et al.NOEY2 (ARHI),an imprinted putative tumor suppressor gene in ovarian and breast carcinomas[J].Proc Natl Acad Sci USA,1999,96:214-219
  • 8Wang L,Hoque A,Luo RZ,et al.Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer[J].Clin Cancer Res,2003,9:3660-3666
  • 9Bao JJ,Le XF,Wang RY,et al.Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain dependent pathway[J].Cancer Res,2002,62:7264-7272
  • 10Kennedy S.Is there a genetic basis to endometriosis[J].Semin Reprod Endocrinol,1997,15:309-318

共引文献12

同被引文献56

  • 1马杰科,张国楠,黄薇.雌激素与子宫内膜异位症的研究进展[J].实用妇产科杂志,2006,22(1):18-20. 被引量:12
  • 2冷金花,郎景和,赵学英,李华军,郭丽娜,崔全才.盆腔子宫内膜异位症病灶分布特点及其腹腔镜诊断准确性的评价[J].中华妇产科杂志,2006,41(2):111-113. 被引量:97
  • 3Palumbo E, Tosoni E, Matricardi L,et al. Genetic instability of the tumor suppressor gene FHIT in normal human cells[J]. Genes Chromosomes Cancer, 2013, 52(9):832-844.
  • 4Rabelo RA, Antunes LM, Etchebehere RM, et al. Loss of heterozygosity in the fragile histidine triad (FHIT) locus and expression analysis of FHIT protein in patients with breast disorders[J]. Clin Exp Obstet Gynecol, 2015,40(1):89-94.
  • 5Sinha R, Hussain S, Mehrotra R, et al. Kras gene mutation and RASSF1A, FHIT and MGMT gene promoter hypermethylation: indicators of tumor staging and metastasis in adenocarcinomatous sporadic colorectal cancer in Indian population [J]. PLoS One,2013,8(4):601-642.
  • 6Saldivar JC, Bene J, Hosseini SA, et al. Characterization of the role of Fhit in suppression of DNA damage[J]. Adv Biol Regul,2013,53(1):77- 85.
  • 7Romero I, Martinez M, Garrido C, et al. The tumour suppressor Fhit pos- itively regulates MHC class I expression on cancer cells[J].J Pathol, 2012,227(3):367-379.
  • 8Jeong Y J, Jeong HY, Lee SM,et al. Promoter methylation status of the FHIT gene and Fhit expression: association with HER2/neu status in breast cancer patients[J]. Oncol Rep,2013,30(5):2270-2278.
  • 9Diaz RJ, Guduk M, Romagnuolo R,et al. High-resolution whole-genome analysis of skull base chordomas implicates FHIT loss in chordoma pathogenesis[J]. Neoplasia,2012,14(9):788-798.
  • 10Mir Mohammadrezaei F, Mohseni kouchesfehani H, Montazeri H, et al. Signaling crosstalk of FHIT, CHK2 and p38 in etoposide induced growth inhibition in MCF-7 cells[J]. Cell Signal,2013,25(1):126-132.

引证文献6

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部